Management Nuances for the Incontinent Prostate Cancer Survivor

The artificial urinary sphincter is an implantable device designed to treat incontinence in prostate cancer survivors. The device has existed for 50 years, and in that time, best practices around its use have undergone several paradigm shifts.

In this video, Jay Simhan, MD, FACS, Professor in the Department of Urology and Director of Reconstruction and Prosthetics at Fox Chase Cancer Center, presents a brief set of updates for providers to consider when treating this patient population.

Topics include:

• Design of the artificial urinary sphincter and how it works
• Perioperative management guidance – avoiding catheters
• Cuff size considerations – smaller isn’t always better
• Double-cuffing – research opposing this practice
• Erosion management and fixing holes in the urethra

Related Presenters

Jay Simhan, MD, FACS, FACS

Vice Chair, Department of Urology
Professor, Department of Urology
Fox Chase-Temple Urologic Institute Provider

Jay Simhan, MD, FACS, specializes in complications from urologic cancer treatment; surgical management and the functional restoration of the kidneys, ureter, bladder, urethra, and penis; urethral stricture disease; penile implant surgery; ...

View full profile